2026. Integrated Network Pharmacology, ADMET Profiling, and Molecular Docking Investigation of Losartan and Its Active Metabolite Against Angiotensin-Related Target. International Journal of Pharmaceutical Research and Medicinal Plants. 2, 5 (Oct. 2026), 76–82. DOI:https://doi.org/10.61280/4sa10p81.